Cost Effectiveness of TNF-𝛼 Inhibitors in Rheumatoid Arthritis

Table 3

Resulting ICERs in terms of improvement in the HAQ.

Patients	Cost differences between Treatment A and B	Difference in HAQ score between Treatment A and B	ICER per unit of improvement in HAQ over 6 months	ICER per 10% improvement in the HAQ over 6 months
Patient 1	€6,451	0.85	€7,589	€2,277
Patient 2	€5,218	0.65	€8,028	€2,408
Patient 3	€5,444	2.15	€2,532	€759.6
Patient 4	€6,489	1.00	€6,489	€1,947
Patient 5	€5,302	0.90	€5,891	€1,767
Patient 6	€6,536	1.05	€6,225	€1,868
Patient 7	€6,476	1.15	€5,631	€1,689
Patient 8	€4,891	2.30	€2,127	€638.1
Patient 9	€5,705	1.30	€4,388	€1,316
Patient 10	€6,508	0.25	€26,030	€7,809
Patient 11	€5,649	1.50	€3,766	€1,130
Patient 12	€6,325	1.10	€5,750	€1,725
Patient 13	€1,802	1.50	€1,201	€360
Average	€5,600	1.20	€6,588	€1,977

The ICERs per unit improvement and per 10% improvement in the HAQ following 6 months of TNF-α inhibitor therapy.